Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17910616rdf:typepubmed:Citationlld:pubmed
pubmed-article:17910616lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:17910616lifeskim:mentionsumls-concept:C0030020lld:lifeskim
pubmed-article:17910616lifeskim:mentionsumls-concept:C0036140lld:lifeskim
pubmed-article:17910616lifeskim:mentionsumls-concept:C0037643lld:lifeskim
pubmed-article:17910616lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:17910616lifeskim:mentionsumls-concept:C2348767lld:lifeskim
pubmed-article:17910616lifeskim:mentionsumls-concept:C0062699lld:lifeskim
pubmed-article:17910616lifeskim:mentionsumls-concept:C0075762lld:lifeskim
pubmed-article:17910616lifeskim:mentionsumls-concept:C0164843lld:lifeskim
pubmed-article:17910616pubmed:issue5lld:pubmed
pubmed-article:17910616pubmed:dateCreated2007-10-3lld:pubmed
pubmed-article:17910616pubmed:abstractTextThe reactivating and therapeutic efficacy of two salts of the oxime HI-6 (dichloride and dimethanesulphonate) against chosen nerve agents (tabun, soman and cyclosarin) was compared in rats. The potency of both salts of HI-6 to decrease the acute toxicity of tabun, soman and cyclosarin was similar in nerve agent-poisoned rats. While the potency of HI-6 dichloride and HI-6 dimethanesulphonate to counteract acute toxic effects of tabun is rather low, both salts of HI-6 were able to decrease the acute toxicity of soman two times and acute toxicity of cyclosarin more than three times. The therapeutic efficacy of both salts of the oxime HI-6 corresponds to their reactivating potency. While the reactivating efficacy of HI-6 dichloride as well as HI-6 dimethanesulphonate against tabun was negligible, their potency to reactivate soman-inhibited acetylcholinesterase and cyclosarin-inhibited acetylcholinesterase in peripheral (blood) and central (brain) compartment was relatively high. HI-6 dichloride showed a somewhat higher potency to reactivate tabun-inhibited acetylcholinesterase in brain, and soman-inhibited acetylcholinesterase in blood and brain than HI-6 dimethanesulphonate but the differences were not significant. Thus, the replacement of dichloride anion by dimethanesulphonate anion in the oxime HI-6 does not influence the therapeutic and reactivating efficacy of the oxime HI-6 against nerve agents. In addition, the higher solubility and stability of HI-6 dimethanesulphonate in comparison with HI-6 dichloride makes it possible to increase the dose and thus, the effectiveness of the oxime HI-6 in the antidotal treatment of acute nerve agent poisonings.lld:pubmed
pubmed-article:17910616pubmed:languageenglld:pubmed
pubmed-article:17910616pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17910616pubmed:citationSubsetIMlld:pubmed
pubmed-article:17910616pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17910616pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17910616pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17910616pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17910616pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17910616pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17910616pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17910616pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17910616pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17910616pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17910616pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17910616pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17910616pubmed:statusMEDLINElld:pubmed
pubmed-article:17910616pubmed:monthNovlld:pubmed
pubmed-article:17910616pubmed:issn1742-7835lld:pubmed
pubmed-article:17910616pubmed:authorpubmed-author:KucaKamilKlld:pubmed
pubmed-article:17910616pubmed:authorpubmed-author:BajgarJiriJlld:pubmed
pubmed-article:17910616pubmed:authorpubmed-author:KassaJiriJlld:pubmed
pubmed-article:17910616pubmed:authorpubmed-author:JunDanielDlld:pubmed
pubmed-article:17910616pubmed:issnTypePrintlld:pubmed
pubmed-article:17910616pubmed:volume101lld:pubmed
pubmed-article:17910616pubmed:ownerNLMlld:pubmed
pubmed-article:17910616pubmed:authorsCompleteYlld:pubmed
pubmed-article:17910616pubmed:pagination328-32lld:pubmed
pubmed-article:17910616pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:17910616pubmed:meshHeadingpubmed-meshheading:17910616...lld:pubmed
pubmed-article:17910616pubmed:meshHeadingpubmed-meshheading:17910616...lld:pubmed
pubmed-article:17910616pubmed:meshHeadingpubmed-meshheading:17910616...lld:pubmed
pubmed-article:17910616pubmed:meshHeadingpubmed-meshheading:17910616...lld:pubmed
pubmed-article:17910616pubmed:meshHeadingpubmed-meshheading:17910616...lld:pubmed
pubmed-article:17910616pubmed:meshHeadingpubmed-meshheading:17910616...lld:pubmed
pubmed-article:17910616pubmed:meshHeadingpubmed-meshheading:17910616...lld:pubmed
pubmed-article:17910616pubmed:meshHeadingpubmed-meshheading:17910616...lld:pubmed
pubmed-article:17910616pubmed:meshHeadingpubmed-meshheading:17910616...lld:pubmed
pubmed-article:17910616pubmed:meshHeadingpubmed-meshheading:17910616...lld:pubmed
pubmed-article:17910616pubmed:meshHeadingpubmed-meshheading:17910616...lld:pubmed
pubmed-article:17910616pubmed:meshHeadingpubmed-meshheading:17910616...lld:pubmed
pubmed-article:17910616pubmed:meshHeadingpubmed-meshheading:17910616...lld:pubmed
pubmed-article:17910616pubmed:year2007lld:pubmed
pubmed-article:17910616pubmed:articleTitleComparison of reactivating and therapeutic efficacy of two salts of the oxime HI-6 against tabun, soman and cyclosarin in rats.lld:pubmed
pubmed-article:17910616pubmed:affiliationDepartment of Toxicology, Faculty of Military Health Sciences, University of Defence, Trebresska 1575, 500 01 Hradec Kralove, Czech Republic. kassa@pmfhk.czlld:pubmed
pubmed-article:17910616pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17910616pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:17910616pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed